South Korean biopharmaceutical company Celltrion said it would invest at least $1 billion to acquire a plant from Eli Lilly ...
Yonhap News Agency on MSN
(2nd LD) Celltrion acquires U.S. biopharma plant from Eli Lilly to counter tariff threats
Celltrion Inc., South Korea's leading biopharmaceutical company, said Tuesday its U.S. subsidiary has signed a deal to ...
The U.S. is planning to ask chipmakers to manufacture at home as many semiconductors as their customers import, aiming to ...
Enterprise software maker Oracle on Monday named insiders Clay Magouyrk and Mike Sicilia as co-CEOs, replacing Safra Catz, ...
Changing your business structure can unlock growth, reduce risk and position your company for long-term success.
GAO rules small business set-asides are discretionary under GSA Schedule, potentially reducing mandatory small business opportunities as more procurements migrate.
Chinese companies are flocking to Hong Kong for IPOs as the U.S. continues to make it more difficult for them to list on U.S. exchanges.
Korea JoongAng Daily on MSN
Celltrion to acquire Eli Lilly plant in U.S. as part of tariff strategy
Celltrion signed a $330 million deal on Tuesday to acquire an Eli Lilly and Company biopharmaceutical plant in New Jersey, securing a U.S. production base as part of its strategy to reduce tariff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results